Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases

Aims. Liver metastases occur in approximately 25% of colorectal cancer (CRC) patients and cause more than 90% of deaths in CRC. Platelets play a crucial role in cancer progression and metastases. We aimed to investigate the relationship between platelet indices and CRC with synchronous liver metasta...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Li, Xiao-Yi Huang, Na Li, Ming-ming Cui, Rui-tao Wang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/6397513
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560252714745856
author Li Li
Xiao-Yi Huang
Na Li
Ming-ming Cui
Rui-tao Wang
author_facet Li Li
Xiao-Yi Huang
Na Li
Ming-ming Cui
Rui-tao Wang
author_sort Li Li
collection DOAJ
description Aims. Liver metastases occur in approximately 25% of colorectal cancer (CRC) patients and cause more than 90% of deaths in CRC. Platelets play a crucial role in cancer progression and metastases. We aimed to investigate the relationship between platelet indices and CRC with synchronous liver metastases. Methods. We conducted a retrospective clinical study including 206 CRC patients without metastases and 200 CRC patients with synchronous liver metastases from January 1, 2015, to December 31, 2017. Data of the patients’ clinicopathological characteristics were collected. Results. Platelet distribution width (PDW) was decreased in CRC patients with liver metastases compared with CRC patients without liver metastases. In addition, the prevalence of liver metastases reduced as PDW quartiles increased. After adjusting for other risk factors, the odds ratios (95% confidence intervals) for CRC liver metastases according to PDW quartiles were 1.000, 0.289 (0.156-0.535), 0.482 (0.271-0.860), and 0.190 (0.101-0.358). Conclusions. Compared with CRC patients without metastases, PDW is reduced in CRC patients with liver metastases. Moreover, PDW was independently associated with the presence of CRC liver metastases.
format Article
id doaj-art-7f514d2cc9c74e988a14a73581cb5679
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-7f514d2cc9c74e988a14a73581cb56792025-02-03T01:28:04ZengWileyGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/63975136397513Platelet Indices in Colorectal Cancer Patients with Synchronous Liver MetastasesLi Li0Xiao-Yi Huang1Na Li2Ming-ming Cui3Rui-tao Wang4Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, ChinaBiotherapy Center, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, ChinaDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, ChinaDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, ChinaDepartment of Internal Medicine, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, ChinaAims. Liver metastases occur in approximately 25% of colorectal cancer (CRC) patients and cause more than 90% of deaths in CRC. Platelets play a crucial role in cancer progression and metastases. We aimed to investigate the relationship between platelet indices and CRC with synchronous liver metastases. Methods. We conducted a retrospective clinical study including 206 CRC patients without metastases and 200 CRC patients with synchronous liver metastases from January 1, 2015, to December 31, 2017. Data of the patients’ clinicopathological characteristics were collected. Results. Platelet distribution width (PDW) was decreased in CRC patients with liver metastases compared with CRC patients without liver metastases. In addition, the prevalence of liver metastases reduced as PDW quartiles increased. After adjusting for other risk factors, the odds ratios (95% confidence intervals) for CRC liver metastases according to PDW quartiles were 1.000, 0.289 (0.156-0.535), 0.482 (0.271-0.860), and 0.190 (0.101-0.358). Conclusions. Compared with CRC patients without metastases, PDW is reduced in CRC patients with liver metastases. Moreover, PDW was independently associated with the presence of CRC liver metastases.http://dx.doi.org/10.1155/2019/6397513
spellingShingle Li Li
Xiao-Yi Huang
Na Li
Ming-ming Cui
Rui-tao Wang
Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
Gastroenterology Research and Practice
title Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
title_full Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
title_fullStr Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
title_full_unstemmed Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
title_short Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases
title_sort platelet indices in colorectal cancer patients with synchronous liver metastases
url http://dx.doi.org/10.1155/2019/6397513
work_keys_str_mv AT lili plateletindicesincolorectalcancerpatientswithsynchronouslivermetastases
AT xiaoyihuang plateletindicesincolorectalcancerpatientswithsynchronouslivermetastases
AT nali plateletindicesincolorectalcancerpatientswithsynchronouslivermetastases
AT mingmingcui plateletindicesincolorectalcancerpatientswithsynchronouslivermetastases
AT ruitaowang plateletindicesincolorectalcancerpatientswithsynchronouslivermetastases